Cargando…

The oral cavity is not a primary source for implantable pacemaker or cardioverter defibrillator infections

BACKGROUND: To test the hypothesis that the oral cavity is a potential source for implantable pacemaker and cardioverter defibrillators infections, the bacterial diversity on explanted rhythm heart management devices was investigated and compared to the oral microbiome. METHODS: A metagenomic approa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eberhard, Jörg, Stumpp, Nico, Ismail, Fadi, Schnaidt, Ulrike, Heuer, Wieland, Pichlmaier, Maximilian, Kühn, Christian, Haverich, Axel, Stiesch, Meike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639834/ https://www.ncbi.nlm.nih.gov/pubmed/23575037 http://dx.doi.org/10.1186/1749-8090-8-73

Ejemplares similares

The Peri-Implant and Periodontal Microbiota in Patients with and without Clinical Signs of Inflammation
por: Jakobi, Meike Luise, et al.
Publicado: (2015)

Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers
por: Watanabe, Eiichi, et al.
Publicado: (2017)

Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators
por: Sabbagh, Ebrahim, et al.
Publicado: (2020)

Automated Implantable Cardioverter Defibrillator/Pacemaker Lead Fracture
por: Rubero, Jose, et al.
Publicado: (2020)

Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology
por: Sahu, Palash, et al.
Publicado: (2023)

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators
por: Burri, Haran, et al.
Publicado: (2009)

Implanted pacemaker and cardioverter-defibrillator in a patient with ectopia cordis
por: Pham, Tam Dan N., et al.
Publicado: (2019)

Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators
por: Pieri, Christopher, et al.
Publicado: (2021)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
por: Abhilash, SP, et al.
Publicado: (2013)

Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators
por: Han, Donghoon, et al.
Publicado: (2019)

Pulsed-field ablation in patients with permanent pacemaker or implantable cardioverter defibrillator: Is it safe?
por: Lennerz, C, et al.
Publicado: (2023)

Experimental Gingivitis Induces Systemic Inflammatory Markers in Young Healthy Individuals: A Single-Subject Interventional Study
por: Eberhard, Jörg, et al.
Publicado: (2013)

DF-4 defibrillator downgrade to pacemaker, a novel method of device downgrade for implantable cardioverter-defibrillator patients
por: Monkhouse, Christopher, et al.
Publicado: (2023)

Radiography of Cardiac Conduction Devices: A Pictorial Review of Pacemakers and Implantable Cardioverter Defibrillators
por: Torres-Ayala, Stephanie C, et al.
Publicado: (2014)

Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
por: Chan, Yin, et al.
Publicado: (2017)

The safety of electrical stimulation in patients with pacemakers and implantable cardioverter defibrillators: A systematic review
por: Badger, James, et al.
Publicado: (2017)

Development of a flow chamber system for the reproducible in vitro analysis of biofilm formation on implant materials
por: Rath, Henryke, et al.
Publicado: (2017)

Pyrosequencing of supra- and subgingival biofilms from inflamed peri-implant and periodontal sites
por: Schaumann, Simone, et al.
Publicado: (2014)

Development and characterization of an oral multispecies biofilm implant flow chamber model
por: Kommerein, Nadine, et al.
Publicado: (2018)

Implantable cardioverter-defibrillators /
Publicado: (1994)

The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems
por: Elliott, Mark K., et al.
Publicado: (2021)

Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction
por: Hauser, Robert G., et al.
Publicado: (2010)

Capsule endoscopy in patients with cardiac pacemakers, implantable cardioverter defibrillators and left heart assist devices
por: Bandorski, Dirk, et al.
Publicado: (2014)

How much heating is associated with magnetic resonance imaging in patients with pacemakers and implantable cardioverter defibrillators?
por: Mason, Steven, et al.
Publicado: (2014)

Establishing radiation therapy treatment planning effects involving implantable pacemakers and implantable cardioverter‐defibrillators
por: Gossman, Michael S., et al.
Publicado: (2009)

Soft Tissue and Skin Reinforcement with Acellular Dermal Matrix to Protect Implanted Cardioverters/Defibrillators and Pacemakers
por: Rudolph, Ross, et al.
Publicado: (2018)

Antibacterial Effect of Cupral(®) on Oral Biofilms - An In-Vitro Study
por: Von Maltzahn, Nadine Freifrau, et al.
Publicado: (2020)

Impact of new X-ray technology on patient dose in pacemaker and implantable cardioverter defibrillator (ICD) implantations
por: van Dijk, Joris D., et al.
Publicado: (2016)

Combining Leadless Pacemaker With a Subcutaneous Implantable Cardioverter-Defibrillator: With Self-Discipline Most Anything Is Possible
por: Ramandi, Mohammad Mostafa Ansari, et al.
Publicado: (2022)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come?
por: Nordbeck, Peter, et al.
Publicado: (2015)

Simultaneous leadless pacemaker and subcutaneous implantable cardioverter‐defibrillator implantation—When vascular options have run out
por: Ng, Jit Beng, et al.
Publicado: (2018)

Hemodynamic response and safety of vasodilator stress cardiovascular magnetic resonance in patients with permanent pacemakers or implantable cardioverter‐defibrillators
por: Miller, Lauren, et al.
Publicado: (2022)

Efficacy and Safety of Transvenous Lead Extraction at the Time of Upgrade from Pacemakers to Cardioverter-Defibrillators and Cardiac Resynchronization Therapy
por: Stefańczyk, Paweł, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_nrrea4m5utbof9gl5d5t5d0118